China Study Tour (CST)

China Industry Insights · Healthcare & MedTech

China Healthcare & MedTech Study Tours: What International Delegations Should Expect

From digital hospitals to biotech R&D centres and medical device manufacturers, China's healthcare innovation ecosystem offers a unique window into how digital health is scaling at population level.

📅 Updated June 2026 ⏱ 8 min read 🩺 Company Visit Guide

Why China's Healthcare & MedTech Sector Is Worth Studying

China's healthcare system is undergoing rapid digitisation — from AI-assisted diagnostics and telemedicine platforms used by hundreds of millions of patients, to biotech firms developing new therapies at speed, to medical device manufacturers supplying both domestic hospitals and export markets. For healthcare executives, investors, hospital administrators and policy researchers, a healthcare and medtech study tour provides direct exposure to how these systems operate at scale.

Programmes in this category typically combine hospital briefings, biotech or medical device company visits, and discussions with digital health platform teams, often supplemented with policy context from local health authorities.

🏥

Hospital & Digital Health Briefings

Visits to leading hospital groups to see digital records systems, AI triage tools and telemedicine consultation platforms in operation.

🧬

Biotech & Pharma R&D

Briefings at biotech companies on drug discovery pipelines, clinical trial infrastructure and partnerships with international firms.

🩻

Medical Device Manufacturing

Factory visits to medical device and diagnostics equipment makers, covering production quality systems and export certification.

📱

Telemedicine & Health Platforms

Demonstrations of consumer-facing health apps, AI symptom checkers and remote consultation services used across China.

What to Expect During a Visit

Hospital Visits

Hospital visits generally take the form of an administrative briefing — often with a vice-president or department director — followed by a walkthrough of selected facilities such as a digital command centre, telemedicine consultation room or a specialist department relevant to the delegation's interest. Clinical areas with active patients are typically not accessible for privacy and operational reasons, but many hospitals are well set up to showcase their digital infrastructure to visiting groups.

Biotech and Pharma Company Visits

Biotech company visits usually begin with a corporate overview covering pipeline focus areas, partnerships and international expansion plans, followed by a Q&A with R&D or business development staff. Access to laboratories varies by company; some offer viewing windows into cleanroom or production areas, while others keep the visit to presentation and discussion format. Companies handling sensitive IP may require a signed NDA in advance.

Medical Device and Diagnostics Manufacturers

These visits resemble standard factory tours — production line walkthroughs, quality control labs and discussion of export certification processes (CE, FDA, NMPA). They are particularly useful for delegations researching supply chain diversification or sourcing partnerships.

Digital Health and Telemedicine Platforms

Briefings with digital health companies typically include live demonstrations of consultation apps, AI-assisted diagnostic tools and data infrastructure, alongside discussion of regulatory frameworks for telemedicine in China.

Sample 6-Day Healthcare & MedTech Itinerary

DayCityFocus
Day 1ShanghaiArrival; briefing on China's healthcare reform and digital health policy landscape
Day 2ShanghaiHospital visit — digital health systems and telemedicine command centre
Day 3ShanghaiBiotech / pharma R&D company briefing
Day 4SuzhouMedical device manufacturer factory visit
Day 5BeijingDigital health / telemedicine platform demonstration and Q&A
Day 6BeijingClosing roundtable, takeaways report, departure

Planning a Healthcare or MedTech Delegation?

China Study Tour (CST) arranges hospital briefings, biotech visits and medical device factory tours for healthcare executives, investors and policy delegations. Get in touch to discuss your itinerary, group size and dates.

Planning Considerations

  • Lead time: Hospital and biotech company visits typically need 4–8 weeks of advance notice for scheduling, security and, where applicable, NDA paperwork.
  • Group size: Hospital briefings work well for groups of 8–20; company visits can usually accommodate up to 25.
  • Access limits: Clinical patient areas and certain R&D labs may be restricted — programmes are designed around what each host can realistically offer.
  • Language support: Bilingual facilitation (English–Mandarin) with familiarity in medical and technical terminology is standard.

Frequently Asked Questions

Can foreign delegations visit hospitals in China?

Yes. Many leading hospitals host international delegations for briefings on digital health systems, telemedicine platforms and specialist departments, though clinical areas with patients usually have restricted access. Visits are arranged in advance through hospital administration or affiliated medical groups.

What do MedTech and biotech company visits in China usually include?

Typical visits include a company overview presentation, a tour of R&D or production facilities where access permits, and a Q&A session with product or business development teams. Some biotech companies require signed NDAs before detailed technical discussions.

Which Chinese cities are best for healthcare and medtech study tours?

Shanghai and Beijing have the highest concentration of biotech R&D centres, major hospital groups and digital health companies. Shenzhen and Suzhou are also strong for medical device manufacturing and health-tech startups.

How far in advance should a healthcare study tour be booked?

Hospital and biotech company visits typically require 4–8 weeks of lead time for scheduling, security clearance and, where applicable, NDA paperwork. Earlier booking gives more flexibility on dates and host availability.

Leave a Reply

Your email address will not be published. Required fields are marked *